Evaluation of the activity of the phosphodiesterase-1 inhibitor ITI-1020 in animal models of triple negative breast cancer.
Research Grant
Administered By
Pharmacology & Cancer Biology
Awarded By
Intra-Cellular Therapies, Inc.
Start Date
July 26, 2024
End Date
July 31, 2026
Administered By
Pharmacology & Cancer Biology
Awarded By
Intra-Cellular Therapies, Inc.
Start Date
July 26, 2024
End Date
July 31, 2026